What clinical trials for biomarkers that are specific for advanced prostate cancer that will make pluvicto more...

Prostate CancerOctober 15, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Here is some relevant information from trusted sources:

According to the National Comprehensive Cancer Network (NCCN) Guidelines for Prostate Cancer, Pluvicto is FDA-approved for the treatment of prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) in patients who have been treated with androgen receptor pathway inhibition and taxane-based chemotherapy. PSMA expression is a key biomarker for determining eligibility for this targeted radioligand therapy.

The American Society of Clinical Oncology (ASCO) states that ongoing clinical trials are evaluating various biomarkers and patient characteristics to better predict response to Pluvicto and optimize patient selection. Some areas of research include:

  1. Quantifying PSMA expression levels to determine if higher expression correlates with improved efficacy
  2. Studying genomic markers like DNA damage repair gene mutations that may impact response
  3. Evaluating other potential predictive markers in the tumor microenvironment

One such trial is the VISION sub-study (NCT03511664), which according to the National Cancer Institute, is analyzing biomarkers in blood and tissue samples to assess their impact on outcomes with Pluvicto in mCRPC.

It's important to discuss your specific case with your oncology team to determine if you may be eligible for any biomarker-driven trials that could help optimize your treatment with Pluvicto or other therapies. They can provide personalized recommendations based on your cancer's features and your overall health.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →